Biggest News Aggregation in the World
📰 Flow Cytometry News

Page 27 - Flow Cytometry News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Flow Cytometry. Real-time updates on events, politics, business and more.

Researcher from The University of Colorado Anschutz medical campus to receive DeNovix Platinum Edition CellDrop

DeNovix Inc. is pleased to announce the winner of the Platinum Edition CellDrop Giveaway: Dr. Christina Roark from The University of Colorado Anschutz Medical Campus, USA! Selected at random from thousands of entries from scientists worldwide, the CellDrop will be housed in Dr. Roark’s lab in the Allergy and Clinical Immunology Division in the Department of Medicine.
United States Andrew Jones Christina Roark Denovix Inc Market Development Clinical Immunology Division

2022 Flow Cytometry Life Science Report: A Snapshot of the Current Market Landscape – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "2022 Flow Cytometry Life Science Dashboard Series 2 (NA & EMEA)" report has been added to ResearchAndMarkets.com's offering. This 2022 Dashboard provides a snapshot of the current market landscape for flow cytometry reagents in North America and Europe. The 2022 flow cytometry Dashboard was developed from responses to…
United States Perkin Elmer Novus Biotechne Milliporesigma Merck Agilent Dako Bioscience Caltag

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cytek Biosciences receives CE marking for series of reagents

Clinical flow cytometry laboratories based in Europe can now purchase Cytek cFluor ® CE-IVD-certified reagents for their use. Cytek Biosciences, Inc. , a cell analysis solutions company, has announced that a series of single-color cFluor reagents and a 6-color TBNK kit have received CE Marking under the European Union In Vitro Diagnostic Medical Devices Directive (IVDD) 98/7
Wenbin Jiang Cytek Biosciences Cytek Biosciences Inc Industry News Northern Lights Cytek Biosciences Receives Ce Marking For Series Of Cfluor Reagents

Solid tumors use a type of T cell as a shield against immune attack

Fred Hutch scientists have identified a subset of immune-calming T cells that show up in great numbers in head and neck cancers, but not in similar tissues inflamed by gum diseases. This odd group of T cells have somehow been tricked into protecting these solid tumors from immune assault, but now might be precisely targeted by drugs to lift that protective shield.
Florian Mair Martin Prlic Jami Erickson Scientists At Fred Hutchinson Cancer Research Center Fred Hutchinson Cancer Research Center Regulatoryt Cell

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

In a recent study published in the journal Frontiers in Immunology, researchers assessed the immune responses induced by vaccination with the messenger ribonucleic acid (mRNA)-1273 vaccine or the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among immunocompromised individuals.
Vaccination Reverses Non Responsiveness Early Antibody Waning Immunocompromised Patients Phase Four Study Comparing Immune Responses Patients With Solid Cancers Multiple Myeloma

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science